nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CYP2E1—Fingolimod—multiple sclerosis	0.173	0.233	CbGbCtD
Methazolamide—CYP2D6—Fingolimod—multiple sclerosis	0.0824	0.111	CbGbCtD
Methazolamide—CYP2E1—Mitoxantrone—multiple sclerosis	0.0813	0.11	CbGbCtD
Methazolamide—CYP3A4—Fingolimod—multiple sclerosis	0.0524	0.0707	CbGbCtD
Methazolamide—CYP2C19—Prednisone—multiple sclerosis	0.0423	0.0571	CbGbCtD
Methazolamide—CYP2E1—Dexamethasone—multiple sclerosis	0.0421	0.0569	CbGbCtD
Methazolamide—SLC22A6—Methotrexate—multiple sclerosis	0.0384	0.0519	CbGbCtD
Methazolamide—CYP3A4—Methylprednisolone—multiple sclerosis	0.0338	0.0456	CbGbCtD
Methazolamide—CYP2C19—Dexamethasone—multiple sclerosis	0.0264	0.0356	CbGbCtD
Methazolamide—CYP3A4—Triamcinolone—multiple sclerosis	0.0256	0.0345	CbGbCtD
Methazolamide—CYP3A4—Mitoxantrone—multiple sclerosis	0.0246	0.0332	CbGbCtD
Methazolamide—CYP2C9—Dexamethasone—multiple sclerosis	0.022	0.0296	CbGbCtD
Methazolamide—CYP3A4—Betamethasone—multiple sclerosis	0.0219	0.0296	CbGbCtD
Methazolamide—CYP3A4—Prednisolone—multiple sclerosis	0.0217	0.0292	CbGbCtD
Methazolamide—CYP3A4—Prednisone—multiple sclerosis	0.0204	0.0276	CbGbCtD
Methazolamide—CYP2D6—Dexamethasone—multiple sclerosis	0.0201	0.0271	CbGbCtD
Methazolamide—CYP3A4—Dexamethasone—multiple sclerosis	0.0128	0.0172	CbGbCtD
Methazolamide—CA1—nerve—multiple sclerosis	0.00368	0.0789	CbGeAlD
Methazolamide—CA4—nerve—multiple sclerosis	0.00288	0.0617	CbGeAlD
Methazolamide—Bone marrow depression—Mitoxantrone—multiple sclerosis	0.00281	0.0132	CcSEcCtD
Methazolamide—Aplastic anaemia—Cladribine—multiple sclerosis	0.00271	0.0128	CcSEcCtD
Methazolamide—Hepatic failure—Cladribine—multiple sclerosis	0.00233	0.011	CcSEcCtD
Methazolamide—Haemolytic anaemia—Cladribine—multiple sclerosis	0.00232	0.0109	CcSEcCtD
Methazolamide—Aplastic anaemia—Azathioprine—multiple sclerosis	0.0022	0.0104	CcSEcCtD
Methazolamide—Leukopenia—Fingolimod—multiple sclerosis	0.00199	0.00938	CcSEcCtD
Methazolamide—CA7—midbrain—multiple sclerosis	0.00196	0.0419	CbGeAlD
Methazolamide—Appetite absent—Methotrexate—multiple sclerosis	0.0019	0.00894	CcSEcCtD
Methazolamide—Hepatic failure—Azathioprine—multiple sclerosis	0.00189	0.00892	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Cladribine—multiple sclerosis	0.00189	0.00888	CcSEcCtD
Methazolamide—CA14—medulla oblongata—multiple sclerosis	0.00178	0.0382	CbGeAlD
Methazolamide—Tingling sensation—Methylprednisolone—multiple sclerosis	0.00178	0.00836	CcSEcCtD
Methazolamide—Glycosuria—Triamcinolone—multiple sclerosis	0.00177	0.00832	CcSEcCtD
Methazolamide—Glycosuria—Methylprednisolone—multiple sclerosis	0.00176	0.0083	CcSEcCtD
Methazolamide—Pancytopenia—Cladribine—multiple sclerosis	0.00172	0.0081	CcSEcCtD
Methazolamide—CA14—midbrain—multiple sclerosis	0.00163	0.0349	CbGeAlD
Methazolamide—Paraesthesia—Fingolimod—multiple sclerosis	0.00163	0.00768	CcSEcCtD
Methazolamide—Tingling sensation—Dexamethasone—multiple sclerosis	0.00162	0.00761	CcSEcCtD
Methazolamide—Tingling sensation—Betamethasone—multiple sclerosis	0.00162	0.00761	CcSEcCtD
Methazolamide—Glycosuria—Betamethasone—multiple sclerosis	0.0016	0.00755	CcSEcCtD
Methazolamide—Glycosuria—Dexamethasone—multiple sclerosis	0.0016	0.00755	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.0016	0.00754	CcSEcCtD
Methazolamide—CA14—spinal cord—multiple sclerosis	0.00159	0.0341	CbGeAlD
Methazolamide—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00157	0.00738	CcSEcCtD
Methazolamide—Fatigue—Fingolimod—multiple sclerosis	0.00157	0.00737	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Azathioprine—multiple sclerosis	0.00153	0.00722	CcSEcCtD
Methazolamide—CA7—cerebellum—multiple sclerosis	0.00151	0.0324	CbGeAlD
Methazolamide—Bone marrow depression—Methotrexate—multiple sclerosis	0.0014	0.00659	CcSEcCtD
Methazolamide—Pancytopenia—Azathioprine—multiple sclerosis	0.0014	0.00658	CcSEcCtD
Methazolamide—Glycosuria—Prednisone—multiple sclerosis	0.0014	0.00657	CcSEcCtD
Methazolamide—Erythema multiforme—Cladribine—multiple sclerosis	0.00137	0.00645	CcSEcCtD
Methazolamide—CA9—cerebellum—multiple sclerosis	0.00133	0.0285	CbGeAlD
Methazolamide—Asthenia—Fingolimod—multiple sclerosis	0.0013	0.00614	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.0013	0.00613	CcSEcCtD
Methazolamide—CA14—cerebellum—multiple sclerosis	0.00126	0.027	CbGeAlD
Methazolamide—Diarrhoea—Fingolimod—multiple sclerosis	0.00124	0.00585	CcSEcCtD
Methazolamide—CA4—brainstem—multiple sclerosis	0.00124	0.0265	CbGeAlD
Methazolamide—CA7—brain—multiple sclerosis	0.00123	0.0264	CbGeAlD
Methazolamide—Agranulocytosis—Azathioprine—multiple sclerosis	0.00122	0.00577	CcSEcCtD
Methazolamide—Ill-defined disorder—Cladribine—multiple sclerosis	0.00117	0.00551	CcSEcCtD
Methazolamide—Headache—Fingolimod—multiple sclerosis	0.00114	0.00536	CcSEcCtD
Methazolamide—Malaise—Cladribine—multiple sclerosis	0.00114	0.00536	CcSEcCtD
Methazolamide—Pancytopenia—Mitoxantrone—multiple sclerosis	0.00113	0.00532	CcSEcCtD
Methazolamide—Erythema multiforme—Azathioprine—multiple sclerosis	0.00111	0.00525	CcSEcCtD
Methazolamide—Discomfort—Cladribine—multiple sclerosis	0.00106	0.005	CcSEcCtD
Methazolamide—Drowsiness—Mitoxantrone—multiple sclerosis	0.00106	0.005	CcSEcCtD
Methazolamide—CA12—nervous system—multiple sclerosis	0.00105	0.0224	CbGeAlD
Methazolamide—Confusional state—Cladribine—multiple sclerosis	0.00104	0.00489	CcSEcCtD
Methazolamide—CA14—brain—multiple sclerosis	0.00103	0.022	CbGeAlD
Methazolamide—CA2—brainstem—multiple sclerosis	0.00102	0.0219	CbGeAlD
Methazolamide—Haematuria—Mitoxantrone—multiple sclerosis	0.00101	0.00476	CcSEcCtD
Methazolamide—CA12—central nervous system—multiple sclerosis	0.00101	0.0216	CbGeAlD
Methazolamide—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00099	0.00466	CcSEcCtD
Methazolamide—CA2—retina—multiple sclerosis	0.000989	0.0212	CbGeAlD
Methazolamide—CA1—spinal cord—multiple sclerosis	0.000983	0.0211	CbGeAlD
Methazolamide—Anorexia—Cladribine—multiple sclerosis	0.000981	0.00462	CcSEcCtD
Methazolamide—Ill-defined disorder—Azathioprine—multiple sclerosis	0.000952	0.00448	CcSEcCtD
Methazolamide—CA5B—nervous system—multiple sclerosis	0.000938	0.0201	CbGeAlD
Methazolamide—Malaise—Azathioprine—multiple sclerosis	0.000925	0.00436	CcSEcCtD
Methazolamide—Paraesthesia—Cladribine—multiple sclerosis	0.000924	0.00435	CcSEcCtD
Methazolamide—Melaena—Methotrexate—multiple sclerosis	0.000923	0.00435	CcSEcCtD
Methazolamide—Leukopenia—Azathioprine—multiple sclerosis	0.000918	0.00432	CcSEcCtD
Methazolamide—Somnolence—Cladribine—multiple sclerosis	0.000915	0.00431	CcSEcCtD
Methazolamide—CA5B—central nervous system—multiple sclerosis	0.000903	0.0193	CbGeAlD
Methazolamide—Decreased appetite—Cladribine—multiple sclerosis	0.000895	0.00421	CcSEcCtD
Methazolamide—SLC22A6—brain—multiple sclerosis	0.000892	0.0191	CbGeAlD
Methazolamide—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000889	0.00419	CcSEcCtD
Methazolamide—Fatigue—Cladribine—multiple sclerosis	0.000888	0.00418	CcSEcCtD
Methazolamide—Aplastic anaemia—Methotrexate—multiple sclerosis	0.000887	0.00418	CcSEcCtD
Methazolamide—Discomfort—Azathioprine—multiple sclerosis	0.000863	0.00406	CcSEcCtD
Methazolamide—CA4—medulla oblongata—multiple sclerosis	0.000862	0.0185	CbGeAlD
Methazolamide—Urine output increased—Methotrexate—multiple sclerosis	0.000854	0.00402	CcSEcCtD
Methazolamide—Feeling abnormal—Cladribine—multiple sclerosis	0.000848	0.004	CcSEcCtD
Methazolamide—CA1—nervous system—multiple sclerosis	0.000829	0.0177	CbGeAlD
Methazolamide—Urticaria—Cladribine—multiple sclerosis	0.000818	0.00385	CcSEcCtD
Methazolamide—Body temperature increased—Cladribine—multiple sclerosis	0.000814	0.00383	CcSEcCtD
Methazolamide—Dysgeusia—Mitoxantrone—multiple sclerosis	0.000812	0.00382	CcSEcCtD
Methazolamide—CA12—brain—multiple sclerosis	0.000799	0.0171	CbGeAlD
Methazolamide—CA1—central nervous system—multiple sclerosis	0.000798	0.0171	CbGeAlD
Methazolamide—CA4—midbrain—multiple sclerosis	0.000788	0.0169	CbGeAlD
Methazolamide—Polyuria—Methotrexate—multiple sclerosis	0.000781	0.00368	CcSEcCtD
Methazolamide—Photosensitivity—Methotrexate—multiple sclerosis	0.000781	0.00368	CcSEcCtD
Methazolamide—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000769	0.00362	CcSEcCtD
Methazolamide—CA4—spinal cord—multiple sclerosis	0.000769	0.0165	CbGeAlD
Methazolamide—Hepatic failure—Methotrexate—multiple sclerosis	0.000763	0.00359	CcSEcCtD
Methazolamide—Malaise—Mitoxantrone—multiple sclerosis	0.000748	0.00352	CcSEcCtD
Methazolamide—Leukopenia—Mitoxantrone—multiple sclerosis	0.000742	0.0035	CcSEcCtD
Methazolamide—Asthenia—Cladribine—multiple sclerosis	0.000739	0.00348	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000723	0.0034	CcSEcCtD
Methazolamide—Convulsion—Mitoxantrone—multiple sclerosis	0.000718	0.00338	CcSEcCtD
Methazolamide—CA5B—brain—multiple sclerosis	0.000717	0.0154	CbGeAlD
Methazolamide—CA2—medulla oblongata—multiple sclerosis	0.000715	0.0153	CbGeAlD
Methazolamide—Diarrhoea—Cladribine—multiple sclerosis	0.000704	0.00332	CcSEcCtD
Methazolamide—Discomfort—Mitoxantrone—multiple sclerosis	0.000697	0.00328	CcSEcCtD
Methazolamide—Feeling abnormal—Azathioprine—multiple sclerosis	0.00069	0.00325	CcSEcCtD
Methazolamide—Confusional state—Mitoxantrone—multiple sclerosis	0.000682	0.00321	CcSEcCtD
Methazolamide—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000677	0.00319	CcSEcCtD
Methazolamide—Body temperature increased—Azathioprine—multiple sclerosis	0.000662	0.00312	CcSEcCtD
Methazolamide—Vomiting—Cladribine—multiple sclerosis	0.000655	0.00308	CcSEcCtD
Methazolamide—CA2—midbrain—multiple sclerosis	0.000653	0.014	CbGeAlD
Methazolamide—CYP2D6—brainstem—multiple sclerosis	0.000651	0.0139	CbGeAlD
Methazolamide—Rash—Cladribine—multiple sclerosis	0.000649	0.00306	CcSEcCtD
Methazolamide—Dermatitis—Cladribine—multiple sclerosis	0.000648	0.00305	CcSEcCtD
Methazolamide—CA4—nervous system—multiple sclerosis	0.000648	0.0139	CbGeAlD
Methazolamide—Anorexia—Mitoxantrone—multiple sclerosis	0.000645	0.00304	CcSEcCtD
Methazolamide—Headache—Cladribine—multiple sclerosis	0.000645	0.00304	CcSEcCtD
Methazolamide—CA2—spinal cord—multiple sclerosis	0.000637	0.0136	CbGeAlD
Methazolamide—CA1—brain—multiple sclerosis	0.000633	0.0136	CbGeAlD
Methazolamide—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000631	0.00297	CcSEcCtD
Methazolamide—CA4—central nervous system—multiple sclerosis	0.000623	0.0134	CbGeAlD
Methazolamide—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000618	0.00291	CcSEcCtD
Methazolamide—Malaise—Prednisolone—multiple sclerosis	0.000613	0.00289	CcSEcCtD
Methazolamide—Dysgeusia—Triamcinolone—multiple sclerosis	0.000613	0.00288	CcSEcCtD
Methazolamide—Nausea—Cladribine—multiple sclerosis	0.000611	0.00288	CcSEcCtD
Methazolamide—Vertigo—Prednisolone—multiple sclerosis	0.000611	0.00288	CcSEcCtD
Methazolamide—CA4—cerebellum—multiple sclerosis	0.000609	0.013	CbGeAlD
Methazolamide—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000608	0.00286	CcSEcCtD
Methazolamide—Somnolence—Mitoxantrone—multiple sclerosis	0.000602	0.00283	CcSEcCtD
Methazolamide—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000596	0.00281	CcSEcCtD
Methazolamide—Convulsion—Prednisolone—multiple sclerosis	0.000589	0.00278	CcSEcCtD
Methazolamide—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000588	0.00277	CcSEcCtD
Methazolamide—Fatigue—Mitoxantrone—multiple sclerosis	0.000583	0.00275	CcSEcCtD
Methazolamide—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00058	0.00273	CcSEcCtD
Methazolamide—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000579	0.00273	CcSEcCtD
Methazolamide—CYP2E1—medulla oblongata—multiple sclerosis	0.000573	0.0123	CbGeAlD
Methazolamide—Diarrhoea—Azathioprine—multiple sclerosis	0.000573	0.0027	CcSEcCtD
Methazolamide—Discomfort—Prednisolone—multiple sclerosis	0.000572	0.00269	CcSEcCtD
Methazolamide—Malaise—Triamcinolone—multiple sclerosis	0.000564	0.00266	CcSEcCtD
Methazolamide—Pancytopenia—Methotrexate—multiple sclerosis	0.000563	0.00265	CcSEcCtD
Methazolamide—Malaise—Methylprednisolone—multiple sclerosis	0.000563	0.00265	CcSEcCtD
Methazolamide—Vertigo—Triamcinolone—multiple sclerosis	0.000562	0.00265	CcSEcCtD
Methazolamide—Vertigo—Methylprednisolone—multiple sclerosis	0.000561	0.00264	CcSEcCtD
Methazolamide—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000558	0.00263	CcSEcCtD
Methazolamide—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000555	0.00261	CcSEcCtD
Methazolamide—Convulsion—Triamcinolone—multiple sclerosis	0.000542	0.00255	CcSEcCtD
Methazolamide—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000541	0.00255	CcSEcCtD
Methazolamide—Convulsion—Methylprednisolone—multiple sclerosis	0.000541	0.00255	CcSEcCtD
Methazolamide—Urticaria—Mitoxantrone—multiple sclerosis	0.000538	0.00253	CcSEcCtD
Methazolamide—CA2—nervous system—multiple sclerosis	0.000537	0.0115	CbGeAlD
Methazolamide—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000535	0.00252	CcSEcCtD
Methazolamide—Vomiting—Azathioprine—multiple sclerosis	0.000532	0.00251	CcSEcCtD
Methazolamide—Drowsiness—Methotrexate—multiple sclerosis	0.000529	0.00249	CcSEcCtD
Methazolamide—Rash—Azathioprine—multiple sclerosis	0.000528	0.00249	CcSEcCtD
Methazolamide—Dermatitis—Azathioprine—multiple sclerosis	0.000527	0.00248	CcSEcCtD
Methazolamide—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000527	0.00248	CcSEcCtD
Methazolamide—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000527	0.00248	CcSEcCtD
Methazolamide—Discomfort—Triamcinolone—multiple sclerosis	0.000526	0.00248	CcSEcCtD
Methazolamide—Discomfort—Methylprednisolone—multiple sclerosis	0.000525	0.00247	CcSEcCtD
Methazolamide—Headache—Azathioprine—multiple sclerosis	0.000524	0.00247	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000524	0.00247	CcSEcCtD
Methazolamide—CA2—central nervous system—multiple sclerosis	0.000517	0.0111	CbGeAlD
Methazolamide—Confusional state—Methylprednisolone—multiple sclerosis	0.000514	0.00242	CcSEcCtD
Methazolamide—Malaise—Betamethasone—multiple sclerosis	0.000512	0.00241	CcSEcCtD
Methazolamide—Malaise—Dexamethasone—multiple sclerosis	0.000512	0.00241	CcSEcCtD
Methazolamide—CYP2E1—spinal cord—multiple sclerosis	0.000511	0.0109	CbGeAlD
Methazolamide—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00051	0.0024	CcSEcCtD
Methazolamide—Vertigo—Betamethasone—multiple sclerosis	0.00051	0.0024	CcSEcCtD
Methazolamide—Vertigo—Dexamethasone—multiple sclerosis	0.00051	0.0024	CcSEcCtD
Methazolamide—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000509	0.0024	CcSEcCtD
Methazolamide—CA2—cerebellum—multiple sclerosis	0.000505	0.0108	CbGeAlD
Methazolamide—Haematuria—Methotrexate—multiple sclerosis	0.000504	0.00237	CcSEcCtD
Methazolamide—Paraesthesia—Prednisolone—multiple sclerosis	0.000498	0.00235	CcSEcCtD
Methazolamide—Nausea—Azathioprine—multiple sclerosis	0.000497	0.00234	CcSEcCtD
Methazolamide—CA4—brain—multiple sclerosis	0.000495	0.0106	CbGeAlD
Methazolamide—Agranulocytosis—Methotrexate—multiple sclerosis	0.000493	0.00232	CcSEcCtD
Methazolamide—Convulsion—Betamethasone—multiple sclerosis	0.000492	0.00232	CcSEcCtD
Methazolamide—Convulsion—Dexamethasone—multiple sclerosis	0.000492	0.00232	CcSEcCtD
Methazolamide—Asthenia—Mitoxantrone—multiple sclerosis	0.000485	0.00229	CcSEcCtD
Methazolamide—Discomfort—Dexamethasone—multiple sclerosis	0.000477	0.00225	CcSEcCtD
Methazolamide—Discomfort—Betamethasone—multiple sclerosis	0.000477	0.00225	CcSEcCtD
Methazolamide—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000463	0.00218	CcSEcCtD
Methazolamide—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000463	0.00218	CcSEcCtD
Methazolamide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000463	0.00218	CcSEcCtD
Methazolamide—Ill-defined disorder—Prednisone—multiple sclerosis	0.000459	0.00216	CcSEcCtD
Methazolamide—Paraesthesia—Triamcinolone—multiple sclerosis	0.000458	0.00216	CcSEcCtD
Methazolamide—Feeling abnormal—Prednisolone—multiple sclerosis	0.000457	0.00215	CcSEcCtD
Methazolamide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000457	0.00215	CcSEcCtD
Methazolamide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000449	0.00212	CcSEcCtD
Methazolamide—Erythema multiforme—Methotrexate—multiple sclerosis	0.000449	0.00211	CcSEcCtD
Methazolamide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000448	0.00211	CcSEcCtD
Methazolamide—Malaise—Prednisone—multiple sclerosis	0.000446	0.0021	CcSEcCtD
Methazolamide—Vertigo—Prednisone—multiple sclerosis	0.000444	0.00209	CcSEcCtD
Methazolamide—Tinnitus—Methotrexate—multiple sclerosis	0.000442	0.00208	CcSEcCtD
Methazolamide—Anorexia—Dexamethasone—multiple sclerosis	0.000442	0.00208	CcSEcCtD
Methazolamide—Anorexia—Betamethasone—multiple sclerosis	0.000442	0.00208	CcSEcCtD
Methazolamide—Urticaria—Prednisolone—multiple sclerosis	0.000441	0.00208	CcSEcCtD
Methazolamide—Fatigue—Triamcinolone—multiple sclerosis	0.00044	0.00207	CcSEcCtD
Methazolamide—Fatigue—Methylprednisolone—multiple sclerosis	0.000439	0.00207	CcSEcCtD
Methazolamide—CYP2E1—nervous system—multiple sclerosis	0.000431	0.00922	CbGeAlD
Methazolamide—Vomiting—Mitoxantrone—multiple sclerosis	0.00043	0.00203	CcSEcCtD
Methazolamide—Convulsion—Prednisone—multiple sclerosis	0.000428	0.00202	CcSEcCtD
Methazolamide—Rash—Mitoxantrone—multiple sclerosis	0.000427	0.00201	CcSEcCtD
Methazolamide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000426	0.00201	CcSEcCtD
Methazolamide—Headache—Mitoxantrone—multiple sclerosis	0.000424	0.002	CcSEcCtD
Methazolamide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000421	0.00198	CcSEcCtD
Methazolamide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00042	0.00198	CcSEcCtD
Methazolamide—Paraesthesia—Dexamethasone—multiple sclerosis	0.000416	0.00196	CcSEcCtD
Methazolamide—Paraesthesia—Betamethasone—multiple sclerosis	0.000416	0.00196	CcSEcCtD
Methazolamide—Discomfort—Prednisone—multiple sclerosis	0.000416	0.00196	CcSEcCtD
Methazolamide—CYP2E1—central nervous system—multiple sclerosis	0.000415	0.00888	CbGeAlD
Methazolamide—CA2—brain—multiple sclerosis	0.00041	0.00879	CbGeAlD
Methazolamide—Dyspepsia—Betamethasone—multiple sclerosis	0.000408	0.00192	CcSEcCtD
Methazolamide—Dyspepsia—Dexamethasone—multiple sclerosis	0.000408	0.00192	CcSEcCtD
Methazolamide—Urticaria—Triamcinolone—multiple sclerosis	0.000406	0.00191	CcSEcCtD
Methazolamide—CYP2E1—cerebellum—multiple sclerosis	0.000405	0.00868	CbGeAlD
Methazolamide—Urticaria—Methylprednisolone—multiple sclerosis	0.000405	0.00191	CcSEcCtD
Methazolamide—Dysgeusia—Methotrexate—multiple sclerosis	0.000405	0.00191	CcSEcCtD
Methazolamide—Body temperature increased—Triamcinolone—multiple sclerosis	0.000404	0.0019	CcSEcCtD
Methazolamide—Anaphylactic shock—Prednisone—multiple sclerosis	0.000403	0.0019	CcSEcCtD
Methazolamide—Decreased appetite—Betamethasone—multiple sclerosis	0.000403	0.0019	CcSEcCtD
Methazolamide—Decreased appetite—Dexamethasone—multiple sclerosis	0.000403	0.0019	CcSEcCtD
Methazolamide—Nausea—Mitoxantrone—multiple sclerosis	0.000402	0.00189	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.0004	0.00188	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.0004	0.00188	CcSEcCtD
Methazolamide—Fatigue—Betamethasone—multiple sclerosis	0.000399	0.00188	CcSEcCtD
Methazolamide—Fatigue—Dexamethasone—multiple sclerosis	0.000399	0.00188	CcSEcCtD
Methazolamide—Anorexia—Prednisone—multiple sclerosis	0.000385	0.00181	CcSEcCtD
Methazolamide—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000383	0.00181	CcSEcCtD
Methazolamide—Feeling abnormal—Betamethasone—multiple sclerosis	0.000382	0.0018	CcSEcCtD
Methazolamide—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000382	0.0018	CcSEcCtD
Methazolamide—Malaise—Methotrexate—multiple sclerosis	0.000373	0.00175	CcSEcCtD
Methazolamide—Vertigo—Methotrexate—multiple sclerosis	0.000371	0.00175	CcSEcCtD
Methazolamide—Leukopenia—Methotrexate—multiple sclerosis	0.00037	0.00174	CcSEcCtD
Methazolamide—Urticaria—Betamethasone—multiple sclerosis	0.000368	0.00173	CcSEcCtD
Methazolamide—Urticaria—Dexamethasone—multiple sclerosis	0.000368	0.00173	CcSEcCtD
Methazolamide—Asthenia—Triamcinolone—multiple sclerosis	0.000366	0.00173	CcSEcCtD
Methazolamide—Body temperature increased—Dexamethasone—multiple sclerosis	0.000366	0.00172	CcSEcCtD
Methazolamide—Body temperature increased—Betamethasone—multiple sclerosis	0.000366	0.00172	CcSEcCtD
Methazolamide—Asthenia—Methylprednisolone—multiple sclerosis	0.000365	0.00172	CcSEcCtD
Methazolamide—Paraesthesia—Prednisone—multiple sclerosis	0.000362	0.00171	CcSEcCtD
Methazolamide—Convulsion—Methotrexate—multiple sclerosis	0.000358	0.00169	CcSEcCtD
Methazolamide—Dyspepsia—Prednisone—multiple sclerosis	0.000355	0.00167	CcSEcCtD
Methazolamide—Decreased appetite—Prednisone—multiple sclerosis	0.000351	0.00165	CcSEcCtD
Methazolamide—Rash—Prednisolone—multiple sclerosis	0.00035	0.00165	CcSEcCtD
Methazolamide—Dermatitis—Prednisolone—multiple sclerosis	0.00035	0.00165	CcSEcCtD
Methazolamide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000349	0.00164	CcSEcCtD
Methazolamide—Fatigue—Prednisone—multiple sclerosis	0.000348	0.00164	CcSEcCtD
Methazolamide—Headache—Prednisolone—multiple sclerosis	0.000348	0.00164	CcSEcCtD
Methazolamide—Discomfort—Methotrexate—multiple sclerosis	0.000347	0.00164	CcSEcCtD
Methazolamide—CYP3A4—nervous system—multiple sclerosis	0.000346	0.00742	CbGeAlD
Methazolamide—CYP2D6—nervous system—multiple sclerosis	0.000341	0.0073	CbGeAlD
Methazolamide—Confusional state—Methotrexate—multiple sclerosis	0.00034	0.0016	CcSEcCtD
Methazolamide—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000337	0.00159	CcSEcCtD
Methazolamide—CYP3A4—central nervous system—multiple sclerosis	0.000334	0.00714	CbGeAlD
Methazolamide—Feeling abnormal—Prednisone—multiple sclerosis	0.000332	0.00157	CcSEcCtD
Methazolamide—Asthenia—Betamethasone—multiple sclerosis	0.000332	0.00157	CcSEcCtD
Methazolamide—Asthenia—Dexamethasone—multiple sclerosis	0.000332	0.00157	CcSEcCtD
Methazolamide—Nausea—Prednisolone—multiple sclerosis	0.00033	0.00155	CcSEcCtD
Methazolamide—CYP2E1—brain—multiple sclerosis	0.000329	0.00705	CbGeAlD
Methazolamide—CYP2D6—central nervous system—multiple sclerosis	0.000328	0.00703	CbGeAlD
Methazolamide—Vomiting—Triamcinolone—multiple sclerosis	0.000325	0.00153	CcSEcCtD
Methazolamide—Vomiting—Methylprednisolone—multiple sclerosis	0.000324	0.00153	CcSEcCtD
Methazolamide—Rash—Triamcinolone—multiple sclerosis	0.000322	0.00152	CcSEcCtD
Methazolamide—Dermatitis—Triamcinolone—multiple sclerosis	0.000322	0.00151	CcSEcCtD
Methazolamide—Anorexia—Methotrexate—multiple sclerosis	0.000321	0.00151	CcSEcCtD
Methazolamide—Rash—Methylprednisolone—multiple sclerosis	0.000321	0.00151	CcSEcCtD
Methazolamide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000321	0.00151	CcSEcCtD
Methazolamide—CYP2D6—cerebellum—multiple sclerosis	0.000321	0.00687	CbGeAlD
Methazolamide—Urticaria—Prednisone—multiple sclerosis	0.00032	0.00151	CcSEcCtD
Methazolamide—Headache—Triamcinolone—multiple sclerosis	0.00032	0.00151	CcSEcCtD
Methazolamide—Headache—Methylprednisolone—multiple sclerosis	0.000319	0.0015	CcSEcCtD
Methazolamide—Body temperature increased—Prednisone—multiple sclerosis	0.000319	0.0015	CcSEcCtD
Methazolamide—Diarrhoea—Betamethasone—multiple sclerosis	0.000317	0.00149	CcSEcCtD
Methazolamide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000317	0.00149	CcSEcCtD
Methazolamide—Nausea—Triamcinolone—multiple sclerosis	0.000303	0.00143	CcSEcCtD
Methazolamide—Paraesthesia—Methotrexate—multiple sclerosis	0.000303	0.00143	CcSEcCtD
Methazolamide—Nausea—Methylprednisolone—multiple sclerosis	0.000303	0.00142	CcSEcCtD
Methazolamide—Somnolence—Methotrexate—multiple sclerosis	0.0003	0.00141	CcSEcCtD
Methazolamide—Dyspepsia—Methotrexate—multiple sclerosis	0.000297	0.0014	CcSEcCtD
Methazolamide—Vomiting—Betamethasone—multiple sclerosis	0.000295	0.00139	CcSEcCtD
Methazolamide—Vomiting—Dexamethasone—multiple sclerosis	0.000295	0.00139	CcSEcCtD
Methazolamide—Decreased appetite—Methotrexate—multiple sclerosis	0.000293	0.00138	CcSEcCtD
Methazolamide—Rash—Dexamethasone—multiple sclerosis	0.000292	0.00138	CcSEcCtD
Methazolamide—Rash—Betamethasone—multiple sclerosis	0.000292	0.00138	CcSEcCtD
Methazolamide—Dermatitis—Betamethasone—multiple sclerosis	0.000292	0.00137	CcSEcCtD
Methazolamide—Dermatitis—Dexamethasone—multiple sclerosis	0.000292	0.00137	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000291	0.00137	CcSEcCtD
Methazolamide—Fatigue—Methotrexate—multiple sclerosis	0.000291	0.00137	CcSEcCtD
Methazolamide—Headache—Betamethasone—multiple sclerosis	0.00029	0.00137	CcSEcCtD
Methazolamide—Headache—Dexamethasone—multiple sclerosis	0.00029	0.00137	CcSEcCtD
Methazolamide—Asthenia—Prednisone—multiple sclerosis	0.000289	0.00136	CcSEcCtD
Methazolamide—Feeling abnormal—Methotrexate—multiple sclerosis	0.000278	0.00131	CcSEcCtD
Methazolamide—Diarrhoea—Prednisone—multiple sclerosis	0.000276	0.0013	CcSEcCtD
Methazolamide—Nausea—Dexamethasone—multiple sclerosis	0.000275	0.0013	CcSEcCtD
Methazolamide—Nausea—Betamethasone—multiple sclerosis	0.000275	0.0013	CcSEcCtD
Methazolamide—Urticaria—Methotrexate—multiple sclerosis	0.000268	0.00126	CcSEcCtD
Methazolamide—Body temperature increased—Methotrexate—multiple sclerosis	0.000266	0.00126	CcSEcCtD
Methazolamide—CYP2D6—brain—multiple sclerosis	0.000261	0.00558	CbGeAlD
Methazolamide—Vomiting—Prednisone—multiple sclerosis	0.000256	0.00121	CcSEcCtD
Methazolamide—Rash—Prednisone—multiple sclerosis	0.000254	0.0012	CcSEcCtD
Methazolamide—Dermatitis—Prednisone—multiple sclerosis	0.000254	0.0012	CcSEcCtD
Methazolamide—Headache—Prednisone—multiple sclerosis	0.000253	0.00119	CcSEcCtD
Methazolamide—Asthenia—Methotrexate—multiple sclerosis	0.000242	0.00114	CcSEcCtD
Methazolamide—Nausea—Prednisone—multiple sclerosis	0.00024	0.00113	CcSEcCtD
Methazolamide—Diarrhoea—Methotrexate—multiple sclerosis	0.000231	0.00109	CcSEcCtD
Methazolamide—Vomiting—Methotrexate—multiple sclerosis	0.000214	0.00101	CcSEcCtD
Methazolamide—Rash—Methotrexate—multiple sclerosis	0.000213	0.001	CcSEcCtD
Methazolamide—Dermatitis—Methotrexate—multiple sclerosis	0.000212	0.001	CcSEcCtD
Methazolamide—Headache—Methotrexate—multiple sclerosis	0.000211	0.000995	CcSEcCtD
Methazolamide—Nausea—Methotrexate—multiple sclerosis	0.0002	0.000943	CcSEcCtD
